265 related articles for article (PubMed ID: 31660895)
21. Retrospective analysis of cancer-specific gene expression panel for thyroid fine needle aspiration specimens.
Wang Y; McKelvey BA; Liu Z; Rooper L; Cope LM; Zeiger MA; Umbricht CB
J Cancer Res Clin Oncol; 2021 Oct; 147(10):2983-2991. PubMed ID: 34165589
[TBL] [Abstract][Full Text] [Related]
22. One in four patients with follicular thyroid cytology (THY3) has a thyroid carcinoma.
Mihai R; Parker AJ; Roskell D; Sadler GP
Thyroid; 2009 Jan; 19(1):33-7. PubMed ID: 18976164
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.
Chen YT; Kitabayashi N; Zhou XK; Fahey TJ; Scognamiglio T
Mod Pathol; 2008 Sep; 21(9):1139-46. PubMed ID: 18587330
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of genetic biomarkers for distinguishing benign from malignant thyroid neoplasms.
Nagar S; Ahmed S; Peeples C; Urban N; Boura J; Thibodeau B; Akervall J; Wilson G; Long G; Czako P
Am J Surg; 2014 Apr; 207(4):596-601. PubMed ID: 24713092
[TBL] [Abstract][Full Text] [Related]
25. [Application value of fine needle aspiration and cell block in preoperative diagnosis of thyroid cancer and discrimination of follicular tumor].
Fang Q; Cai C; Chen H
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Aug; 50(8):668-72. PubMed ID: 26696207
[TBL] [Abstract][Full Text] [Related]
26. Molecular classification of thyroid nodules by cytology.
Pagedar NA; Chen DH; Wasman JK; Savvides P; Schluchter MD; Wilhelm SM; Lavertu P
Laryngoscope; 2008 Apr; 118(4):692-6. PubMed ID: 18094649
[TBL] [Abstract][Full Text] [Related]
27. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
28. Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.
Stokowy T; Wojtas B; Jarzab B; Krohn K; Fredman D; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Paschke R; Eszlinger M
Endocrine; 2016 Nov; 54(2):440-447. PubMed ID: 27473101
[TBL] [Abstract][Full Text] [Related]
29. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates.
Marchetti I; Lessi F; Mazzanti CM; Bertacca G; Elisei R; Coscio GD; Pinchera A; Bevilacqua G
Thyroid; 2009 Aug; 19(8):837-42. PubMed ID: 19534623
[TBL] [Abstract][Full Text] [Related]
30. Assessment of molecular testing in fine-needle aspiration biopsy samples: an experience in a Chinese population.
Liu S; Gao A; Zhang B; Zhang Z; Zhao Y; Chen P; Ji M; Hou P; Shi B
Exp Mol Pathol; 2014 Oct; 97(2):292-7. PubMed ID: 25111330
[TBL] [Abstract][Full Text] [Related]
31. Development of a microRNA-based molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples.
Mazeh H; Mizrahi I; Halle D; Ilyayev N; Stojadinovic A; Trink B; Mitrani-Rosenbaum S; Roistacher M; Ariel I; Eid A; Freund HR; Nissan A
Thyroid; 2011 Feb; 21(2):111-8. PubMed ID: 21275764
[TBL] [Abstract][Full Text] [Related]
32. Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis.
Marchetti I; Iervasi G; Mazzanti CM; Lessi F; Tomei S; Naccarato AG; Aretini P; Alberti B; Di Coscio G; Bevilacqua G
Thyroid; 2012 Mar; 22(3):292-8. PubMed ID: 22181337
[TBL] [Abstract][Full Text] [Related]
33. Telomerase activity in thyroid fine needle aspirates.
Mora J; Lerma E;
Acta Cytol; 2004; 48(6):818-24. PubMed ID: 15581168
[TBL] [Abstract][Full Text] [Related]
34. Telomerase activity in "suspicious" thyroid cytology.
Lerma E; Mora J
Cancer; 2005 Dec; 105(6):492-7. PubMed ID: 16104043
[TBL] [Abstract][Full Text] [Related]
35. In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
Guo Z; Hardin H; Montemayor-Garcia C; Asioli S; Righi A; Maletta F; Sapino A; Lloyd RV
Endocr Pathol; 2015 May; 26(2):157-63. PubMed ID: 25771986
[TBL] [Abstract][Full Text] [Related]
36. A panel of four genes accurately differentiates benign from malignant thyroid nodules.
Wang QX; Chen ED; Cai YF; Li Q; Jin YX; Jin WX; Wang YH; Zheng ZC; Xue L; Wang OC; Zhang XH
J Exp Clin Cancer Res; 2016 Oct; 35(1):169. PubMed ID: 27793213
[TBL] [Abstract][Full Text] [Related]
37. Preoperative diagnosis of the follicular variant of papillary carcinoma of the thyroid: discrepancy between image and cytologic diagnoses.
Komatsu M; Hanamura N; Tsuchiya S; Seki T; Kuroda T
Radiat Med; 1994; 12(6):293-9. PubMed ID: 7724824
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of the candidate microRNAs in thyroid fine-needle aspiration biopsy (FNAB) samples.
Mahmoudian-Sani MR; Amrollahi-Sharifabadi M; Taheri A; Hosseini SM; Tahmasebi K; Mobini GR
Horm Mol Biol Clin Investig; 2020 Mar; 41(2):. PubMed ID: 32167927
[TBL] [Abstract][Full Text] [Related]
39. Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma.
Zhao L; Dias-Santagata D; Sadow PM; Faquin WC
Cancer Cytopathol; 2017 May; 125(5):323-331. PubMed ID: 28192645
[TBL] [Abstract][Full Text] [Related]
40. A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.
Fassina A; Cappellesso R; Simonato F; Siri M; Ventura L; Tosato F; Busund LT; Pelizzo MR; Fassan M
Cancer Cytopathol; 2014 Apr; 122(4):274-81. PubMed ID: 24327568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
